Adjustable Phakic Intraocular Lens

Information

  • Research Project
  • 6692869
  • ApplicationId
    6692869
  • Core Project Number
    R43EY015040
  • Full Project Number
    1R43EY015040-01
  • Serial Number
    15040
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/1/2003 - 21 years ago
  • Project End Date
    7/31/2004 - 20 years ago
  • Program Officer Name
    HELMSEN, RALPH J
  • Budget Start Date
    8/1/2003 - 21 years ago
  • Budget End Date
    7/31/2004 - 20 years ago
  • Fiscal Year
    2003
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/25/2003 - 21 years ago
Organizations

Adjustable Phakic Intraocular Lens

DESCRIPTION (provided by applicant): The increasing demand for spectacle-free refractive correction has generated interest in the use of phakic IOLs for refractive correction of high myopia. While LASIK has been highly successful for hyperopia and myopia up to approximately 10 D, the correction of larger refractive errors has had limited success because of the need to ablate excessive corneal tissue. The challenge of today's phakic IOLs remains to deliver precise, accurate and permanent correction of spherical and astigmatic refractive error. The objective of this program is to develop a soft acrylic light adjustable phakic intraocular lens (LAL) for the treatment of high myopia and high myopia with astigmatism. The phakic LAL is an IOL whose power can be precisely adjusted with light 2-4 weeks after implantation to correct any refractive errors due to incorrect power calculations, the surgical procedure and wound healing to insure the patient is spectacle free after surgery. The soft acrylic material is chosen because of its high refractive index to reduce lens thickness and thereby minimize the incidence of endothelial or iris cell loss, and cataract formation of the healthy natural lens by reducing the risk of contact of the implanted phakic lens with these cells. The primary goal in Phase I is to select the acrylic material for phakic IOLs for high myopia and myopia with astigmatism and demonstrate the power change through shape or refractive index change or both. In order to achieve the goal, six aims are proposed: (1) Develop a soft acrylic LAL composition based on initial exploratory work, (2) Characterize the test formulations for optical clarity and refractive index, (3) Evaluate the photoreactivity of the macromer in cured test formulations by Differential Photocalori-metry (DPC), (4) Determine the level of available unreacted monomer remaining after crosslinking of the matrix by thermal initiation using GC and GPC analyses of solvent extractables, (5) Fabricate test lenses from test formulations and evaluate for power adjustment by interferometric measurement to identify range of feasible power change, and (6) Select the candidate material for Phase II development based upon the test data generated in Phase I.

IC Name
NATIONAL EYE INSTITUTE
  • Activity
    R43
  • Administering IC
    EY
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    163086
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    867
  • Ed Inst. Type
  • Funding ICs
    NEI:163086\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CALHOUN VISION, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    PASADENA
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    91107
  • Organization District
    UNITED STATES